Acta Chromatographica
Volume/Issue:
Volume 25: Issue 2
Using LC-MS/MS to study dauricine pharmacokinetics and determine its bioavailability following administration in different routes
Authors:
X. Gao Department of Clinical Pharmacy and Pharmacy Administration, West China School of Pharmacy, Sichuan University, Chengdu, Sichuan, China
Department of Pharmacy, Chengdu Medical College, Chengdu, Sichuan, China

Search for other papers by X. Gao in
Current site
Google Scholar
PubMed Close
,
X. Jiang Department of Clinical Pharmacy and Pharmacy Administration, West China School of Pharmacy, Sichuan University, Chengdu, Sichuan, China

Search for other papers by X. Jiang in
Current site
Google Scholar
PubMed Close
, and
L. Wang Department of Clinical Pharmacy and Pharmacy Administration, West China School of Pharmacy, Sichuan University, Chengdu, Sichuan, China

Search for other papers by L. Wang in
Current site
Google Scholar
PubMed Close
Pages:
241–256
Online Publication Date:
01 Jun 2013
Publication Date:
01 Jun 2013
Article Category:
Research Article
DOI:
https://doi.org/10.1556/achrom.25.2013.2.3
Keywords:
dauricine; LC-MS/MS; rat plasma; pharmacokinetic study; absolute bioavailability
Open access

Summary

Dauricine has a variety of pharmacological properties including anti-inflammatory, anti-arrhythmic, and antihypertensive effects as well as reversing multidrug resistance (MDR) of cancer cells. While its therapeutic application is increasing, its bioavailability of different administration routes has not been studied. In the present study, we developed and validated a liquid chromatography/electrospray ionization mass spectrometry method (LC-MS/MS). Using this method, we quantified dauricine in rat plasma after administration via intravenous (i.v.) injection, per oral (p.o.), and intraperitoneal injection (i.p.). Our results indicated that this method detected plasma dauricine with a good linearity in the range of 1.95–1000.00 ng/mL (r = 0.9997). The extraction method showed an average intra- and inter-day recovery of 98.21–104.35% and 98.0–103.58%, respectively. Dauricine showed a fast absorption and widespread distribution after administration in all three tested routes. After intravenous administration (2.5, 5.0, 10.0 mg/kg), the pharmacokinetics of dauricine exhibited a first-order kinetics. In addition, dauricine showed a slow elimination with a long half-life (t1/2z) and double peaks phenomenon following p.o. and i.p. administration. Furthermore, using area under the plasma concentration-time curve (AUC), we calculated absolute bioavailability, which was over twofold higher when administered via i.p. than via p.o. administration. The newly obtained information from our study will provide important reference for dauricine dose and administration route in designing dauricine therapy for applicable diseases.

  • [1]. M.C. Li D.Y. Huang 2008 Chin. Pharm. J. 43 1875–1877.

  • [2]. Z.K. Huang 2004 Modern Journal of Integrated Traditional Chinese and Western Medicine 13 718–719.

  • [3]. Q.Y. Li J.Y. Wang J.J. Cheng 2010 Progress in Veterinary Medicine 31 115–117.

  • [4]. Pharmacopoeia Commission of People's Republic of China. Pharmacopoeia of People's Republic of China, 1st edn. Chemical Industry Press, Beijing, 2005.

    • Search Google Scholar
    • Export Citation

  • [5]. Y. Zhang C. Sun Q.C. Guan et al.2009 Modern Pharmacy and Clinic 24 367–368.

  • [6]. M. Li B.E. Shan 2005 International Journal of Traditional Chinese Medicine 27 267–271.

  • [7]. X.Q. Zhu T.G. Han 2007 Journal of Chengde Medical College 24 418–420.

  • [8]. X.D. Huang D. Han X.Y. Cui 2007 Medical Journal of Chinese People's Health 19 575–576.

  • [9]. J.Q. Qian 2002 Acta Pharmacol Sin 23 1086–1092.

  • [10]. H. Tian Q.C. Pan 1996 Cancer 15 410–414.

  • [11]. J.H. Li F.Q. Qin P.M. Yang 2002 Journal of Dalian Medical University 24 94–96.

  • [12]. L. He G.Q. Liu 2002 Acta Pharmacol Sin 23 591–596.

  • [13]. F.M. Han Z.H. Peng W. Song et al.2007 Journal of Chromatography B 854 1–7.

  • [14]. X.Y. Liu Q. Liu D.M. Wang et al.2010 Journal of Chromatography B 878 1199–1203.

  • [15]. S.J. Chen B. Zhang Y.M. Yang Z.S. Dai et al.2000 Chinese Journal Of Clinical Pharmacology and Therapeutics 5 213–217.

  • [16]. S.J. Chen Y.M. Yang 2001 Chinese Pharmacological Bulletin 17 225–229.

  • [17]. R. Sun C. Wang 2009 Chinese Journal of Pharmacovigilance 6 546–549.

  • [18]. V.J. Wacher L. Salphati L.Z. Benet 2001 Advanced Drug Delivery Reviews 46 89–102.

  • Collapse
  • Expand
Cover Acta Chromatographica
Acta Chromatographica
Online ISSN:
2083-5736

Senior editors

Editor(s)-in-Chief: Sajewicz, Mieczyslaw, University of Silesia, Katowice, Poland

Editors(s)

  • Danica Agbaba, University of Belgrade, Belgrade, Serbia (1953-2024)
  • Łukasz Komsta, Medical University of Lublin, Lublin, Poland
  • Ivana Stanimirova-Daszykowska, University of Silesia, Katowice, Poland
  • Monika Waksmundzka-Hajnos, Medical University of Lublin, Lublin, Poland

Editorial Board

  • Ravi Bhushan, The Indian Institute of Technology, Roorkee, India
  • Jacek Bojarski, Jagiellonian University, Kraków, Poland
  • Bezhan Chankvetadze, State University of Tbilisi, Tbilisi, Georgia
  • Michał Daszykowski, University of Silesia, Katowice, Poland
  • Tadeusz H. Dzido, Medical University of Lublin, Lublin, Poland
  • Attila Felinger, University of Pécs, Pécs, Hungary
  • Kazimierz Glowniak, Medical University of Lublin, Lublin, Poland
  • Bronisław Glód, Siedlce University of Natural Sciences and Humanities, Siedlce, Poland
  • Anna Gumieniczek, Medical University of Lublin, Lublin, Poland
  • Urszula Hubicka, Jagiellonian University, Kraków, Poland
  • Krzysztof Kaczmarski, Rzeszow University of Technology, Rzeszów, Poland
  • Huba Kalász, Semmelweis University, Budapest, Hungary
  • Katarina Karljiković Rajić, University of Belgrade, Belgrade, Serbia
  • Imre Klebovich, Semmelweis University, Budapest, Hungary
  • Angelika Koch, Private Pharmacy, Hamburg, Germany
  • Piotr Kus, Univerity of Silesia, Katowice, Poland
  • Debby Mangelings, Free University of Brussels, Brussels, Belgium
  • Emil Mincsovics, Corvinus University of Budapest, Budapest, Hungary
  • Ágnes M. Móricz, Centre for Agricultural Research, Budapest, Hungary
  • Gertrud Morlock, Giessen University, Giessen, Germany
  • Anna Petruczynik, Medical University of Lublin, Lublin, Poland
  • Robert Skibiński, Medical University of Lublin, Lublin, Poland
  • Bernd Spangenberg, Offenburg University of Applied Sciences, Germany
  • Tomasz Tuzimski, Medical University of Lublin, Lublin, Poland
  • Adam Voelkel, Poznań University of Technology, Poznań, Poland
  • Beata Walczak, University of Silesia, Katowice, Poland
  • Wiesław Wasiak, Adam Mickiewicz University, Poznań, Poland
  • Igor G. Zenkevich, St. Petersburg State University, St. Petersburg, Russian Federation

 

SAJEWICZ, MIECZYSLAW
E-mail:mieczyslaw.sajewicz@us.edu.pl

Indexing and Abstracting Services:

  • Science Citation Index
  • SCOPUS
  • DOAJ
  • Sci Search
  • Research Alert
  • Chemistry Citation Index and Current Content/Physical
  • Chemical and Earth Sciences
  • GoogleScholar
  • Index Copernicus
  • CABI
  • CABELLS Journalytics

2024  
Scopus  
CiteScore  
CiteScore rank  
SNIP  
Scimago  
SJR index 0.285
SJR Q rank Q3

2023  
Web of Science  
Journal Impact Factor 1.7
Rank by Impact Factor Q3 (Chemistry, Analytical)
Journal Citation Indicator 0.43
Scopus  
CiteScore 4.0
CiteScore rank Q2 (General Chemistry)
SNIP 0.706
Scimago  
SJR index 0.344
SJR Q rank Q3

Acta Chromatographica
Publication Model Online only
Gold Open Access
Submission Fee none
Article Processing Charge

700 EUR/article

For MS submitted before 1 Feb 2025: 400 EUR/article
Regional discounts on country of the funding agency World Bank Lower-middle-income economies: 50%
World Bank Low-income economies: 100%
Further Discounts Editorial Board / Advisory Board members: 50%
Corresponding authors, affiliated to an EISZ member institution subscribing to the journal package of Akadémiai Kiadó: 100%
Subscription Information Gold Open Access
Purchase per Title  

Acta Chromatographica
Language English
Size A4
Year of
Foundation		 1988
Volumes
per Year		 1
Issues
per Year		 4
Founder Institute of Chemistry, University of Silesia
Founder's
Address		 PL-40-007 Katowice, Poland, Bankowa 12
Publisher Akadémiai Kiadó
Publisher's
Address		 H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Responsible
Publisher		 Chief Executive Officer, Akadémiai Kiadó
ISSN 2083-5736 (Online)

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Dec 2024 0 85 0
Jan 2025 0 38 5
Feb 2025 0 48 0
Mar 2025 0 57 6
Apr 2025 0 30 6
May 2025 0 42 44
Jun 2025 0 16 0